Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pancreatic Neoplasms 3 Colorectal Neoplasms 2 Colonic Neoplasms 2 Prostatic Neoplasms 1 Pain, Postoperative 1 Pain 1 Neoplasms 1 Kidney Neoplasms 1 Intraoperative Complications 1 Inflammatory Bowel Diseases 1 Fibroadenoma 1 Diverticulitis 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bone Neoplasms 1 Arrhythmias, Cardiac 1 Anesthesia 1

Interventions

Nivolumab 74 Sunitinib 73 pembrolizumab 49 Everolimus 39 Sorafenib 36 Bevacizumab 36 Axitinib 36 cabozantinib 35 Radiosurgery 33 Ipilimumab 33 pazopanib 32 Magnetic Resonance Spectroscopy 27 Interleukin-2 27 aldesleukin 23 Specimen Handling 22 Cyclophosphamide 21 lenvatinib 20 fludarabine phosphate 17 Radiotherapy 16 Interferon-alpha 15 Peripheral Blood Stem Cell Transplantation 14 Gemcitabine 14 Biopsy 14 temsirolimus 13 Nephrectomy 13 durvalumab 11 Immunohistochemistry 11 CTLA-4 Antigen 11 Blood Specimen Collection 11 Capecitabine 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Renal Cell × Anesthesia, Epidural × Clear all

NCT02030717 2015-06-04

ASA

Umeå University

Phase 2/3 Completed

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡